145 related articles for article (PubMed ID: 25712535)
21. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy induces enhanced procoagulant activity through phosphatidylserine exposure in acute lymphoblastic leukemia.
Dong X; Shi J; Zhou J; Chen X; Jin Y; Zhang X; Li X; Dai H; Wang J
Thromb Res; 2013 Nov; 132(5):614-20. PubMed ID: 24074703
[TBL] [Abstract][Full Text] [Related]
23. Recommendations for the use of long-term central venous catheter (CVC) in children with hemato-oncological disorders: management of CVC-related occlusion and CVC-related thrombosis. On behalf of the coagulation defects working group and the supportive therapy working group of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
Giordano P; Saracco P; Grassi M; Luciani M; Banov L; Carraro F; Crocoli A; Cesaro S; Zanazzo GA; Molinari AC;
Ann Hematol; 2015 Nov; 94(11):1765-76. PubMed ID: 26300457
[TBL] [Abstract][Full Text] [Related]
24. Thrombosis and acute lymphoblastic leukaemia.
Payne JH; Vora AJ
Br J Haematol; 2007 Aug; 138(4):430-45. PubMed ID: 17608766
[TBL] [Abstract][Full Text] [Related]
25. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of venous thrombosis in children with cancer.
Piovesan D; Attard C; Monagle P; Ignjatovic V
Thromb Haemost; 2014 Jun; 111(6):1015-21. PubMed ID: 24522152
[TBL] [Abstract][Full Text] [Related]
27. Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies.
Falanga A; Rickles FR
Hematology Am Soc Hematol Educ Program; 2007; ():165-71. PubMed ID: 18024625
[TBL] [Abstract][Full Text] [Related]
28. Catheter-related thrombosis in cancer patients.
Murray J; Precious E; Alikhan R
Br J Haematol; 2013 Sep; 162(6):748-57. PubMed ID: 23848991
[TBL] [Abstract][Full Text] [Related]
29. Occluded Tunneled Venous Catheter in Hemodialysis Patients: Risk Factors and Efficacy of Alteplase.
Ponce D; Mendes M; Silva T; Oliveira R
Artif Organs; 2015 Sep; 39(9):741-7. PubMed ID: 25894244
[TBL] [Abstract][Full Text] [Related]
30. [Complications associated to central venous catheters in hematology patients].
García-Gabás C; Castillo-Ayala A; Hinojo-Marín B; Muriel-Abajo MÁ; Gómez-Gutiérrez I; de Mena-Arenas AM; Rodríguez-Gonzalo A; Chao-Lozano C; García-Menéndez C; Madroñero-Agreda MA
Enferm Clin; 2015; 25(3):138-42. PubMed ID: 25959637
[TBL] [Abstract][Full Text] [Related]
31. Thrombotic complications of central venous catheters in cancer patients.
Bona RD
Semin Thromb Hemost; 1999; 25(2):147-55. PubMed ID: 10357082
[TBL] [Abstract][Full Text] [Related]
32. Risk of thrombosis in cancer and the role of supportive care (transfusion, catheters, and growth factors).
Castaman G
Thromb Res; 2016 Apr; 140 Suppl 1():S89-92. PubMed ID: 27067986
[TBL] [Abstract][Full Text] [Related]
33. Thrombosis in stem cell transplantation.
Kansu E
Hematology; 2012 Apr; 17 Suppl 1():S159-62. PubMed ID: 22507809
[TBL] [Abstract][Full Text] [Related]
34. [Prophylaxis of thrombosis induced by chemotherapy or central venous catheters].
Voog E; Lazard E; Juhel L
Presse Med; 2007 Feb; 36(2 Pt 1):225-34. PubMed ID: 17259031
[TBL] [Abstract][Full Text] [Related]
35. Prevention of thrombotic disorders in cancer patients undergoing chemotherapy.
Levine MN
Thromb Haemost; 1997 Jul; 78(1):133-6. PubMed ID: 9198142
[TBL] [Abstract][Full Text] [Related]
36. The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia.
Truelove E; Fielding AK; Hunt BJ
Leukemia; 2013 Mar; 27(3):553-9. PubMed ID: 23099335
[TBL] [Abstract][Full Text] [Related]
37. Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.
Dally N; Hoffman R; Haddad N; Sarig G; Rowe JM; Brenner B
Thromb Res; 2005; 116(2):109-14. PubMed ID: 15907524
[TBL] [Abstract][Full Text] [Related]
38. Central venous catheterization and thrombosis in newborns: update on diagnosis and management.
Sellitto M; Messina F
J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():26-8. PubMed ID: 22958007
[TBL] [Abstract][Full Text] [Related]
39. Totally implantable central venous catheters of the port-a-cath type: complications due to its use in the treatment of cancer patients.
Granic M; Zdravkovic D; Krstajic S; Kostic S; Simic A; Sarac M; Ivanovic N; Radovanovic D; Dikic S; Kovcin V
J BUON; 2014; 19(3):842-6. PubMed ID: 25261677
[TBL] [Abstract][Full Text] [Related]
40. [Venous thromboembolism and cancer].
Pavic M; Debourdeau P; Aletti M; Farge-Bancel D; Rousset H
Rev Med Interne; 2006 Apr; 27(4):313-22. PubMed ID: 16414153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
